Q: Where is MD&A in a 10-K?
A: MD&A is Item 7 of Form 10-K. In a Form 10-Q it is Item 2 of Part I, directly after the financial statements.
MD&A (Management's Discussion and Analysis)
Regulation S-K Item 303
Definition
Management's Discussion and Analysis (MD&A) is the narrative section of a 10-K or 10-Q in which a company's management explains, in its own words, what drove the reported financial results, how its liquidity and capital resources stand, and which known trends or uncertainties could make past results a poor guide to the future. Its content is governed by Item 303 of Regulation S-K.
The SEC's stated aim for MD&A is to let investors see the business the way management sees it. Where the financial statements report what happened, MD&A is supposed to explain why.
Full guide: How to Read a 10-K Annual Report: A Value Investor's Guide (2026)
Details
MD&A appears as Item 7 of Form 10-K and as Item 2 of Part I of Form 10-Q. For full fiscal years, Item 303(b) asks for three core discussions. Liquidity and capital resources covers the company's ability to generate and raise cash, analyzed separately for the next 12 months and for the period beyond, including material cash requirements from contractual obligations. Results of operations covers unusual events that affected income, known trends likely to move revenue or costs, and whether revenue changes came from price, volume, or new products. Critical accounting estimates covers the judgments with significant estimation uncertainty that have had, or could have, a material effect, and how sensitive the reported numbers are to them.
The rule tells companies not to simply restate figures that can be read off the statements. When the financial statements cover three years, the discussion of the earliest year may be dropped if it already appeared in a prior EDGAR filing, provided the company says where. Smaller reporting companies cover two years. Quarterly MD&A compares year-to-date results with the prior year-to-date period, and the latest quarter with either the same quarter a year earlier or the immediately preceding quarter.
GeminIQ's metrics are computed from the reported financial statements; MD&A is where a company explains the movements those metrics show.
FAQ
Q: Is MD&A audited?
A: No. The auditor's opinion covers the financial statements and notes, not the MD&A narrative. Forward-looking statements in MD&A fall under the safe harbor rules for projections cited in Item 303.
Q: What are critical accounting estimates?
A: They are GAAP estimates that carry significant estimation uncertainty and that have materially affected, or could plausibly materially affect, results or financial condition. MD&A must explain why each is uncertain and how sensitive the reported amounts are to the assumptions behind it.
Related Terms
GeminIQ turns SEC EDGAR filings into interactive fundamental analysis. Explore the financial ratios and metrics library or start screening every US public company.
Start 7-Day Free Trial →